Telomeropathies are rare disorders associated with impaired telomere length control mechanisms that frequently result from genetic mutations in the telomerase complex. Dyskeratosis congenita is a congenital progressive telomeropathy in which mutation in the telomerase RNA component (TERC) impairs telomere maintenance leading to accelerated cellular senescence and clinical outcomes resembling premature aging. The most severe clinical feature is perturbed hematopoiesis and bone-marrow failure, but the underlying mechanisms are not fully understood. Here, we developed a model of telomerase function imbalance using shRNA to knockdown TERC expression in human induced pluripotent stem cells (iPSCs). We then promoted in vitro hematopoiesis in these cells to analyze the effects of TERC impairment. Reduced TERC expression impaired hematopoietic stem-cell (HSC) differentiation and increased the expression of cellular senescence markers and production of reactive oxygen species. Interestingly, telomere length was unaffected in shTERC knockdown iPSCs, leading to conclusion that the phenotype is controlled by non-telomeric functions of telomerase. We then assessed the effects of TERC-depletion in THP-1 myeloid cells and again observed reduced hematopoietic and myelopoietic differentiative potential. However, these cells exhibited impaired telomerase activity as verified by accelerated telomere shortening. shTERC-depleted iPSC-derived and THP-1-derived myeloid precursors had lower phagocytic capacity and increased ROS production, indicative of senescence. These findings were confirmed using a BIBR1532 TERT inhibitor, suggesting that these phenotypes are dependent on telomerase function but not directly linked to telomere length. These data provide a better understanding of the molecular processes driving the clinical signs of telomeropathies and identify novel roles of the telomerase complex other than regulating telomere length.

Cellular and Molecular Immunoregulation Group Center for Translational Medicine International Clinical Research Center St Anne's University Hospital Brno Brno Czechia

Department of Biology Faculty of Medicine Masaryk University Brno Czechia

Pediatric Hematology and Oncology The University Hospital Brno Brno Czechia

Pediatric Oncology Translational Research International Clinical Research Center St Anne's University Hospital Brno Brno Czechia

Zobrazit více v PubMed

Agarwal S., Loh Y. H., McLoughlin E. M., Huang J., Park I. H., Miller J. D., et al. (2010). Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. PubMed DOI PMC

Akbar A. N., Vukmanovic-Stejic M. (2007). Telomerase in T lymphocytes: use it and lose it? PubMed DOI

Akiyama M., Asai O., Kuraishi Y., Urashima M., Hoshi Y., Sakamaki H., et al. (2000). Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation. PubMed DOI

Alcaraz-Perez F., Garcia-Castillo J., Garcia-Moreno D., Lopez-Munoz A., Anchelin M., Angosto D., et al. (2014). A non-canonical function of telomerase RNA in the regulation of developmental myelopoiesis in zebrafish. PubMed DOI

Armanios M., Alder J. K., Parry E. M., Karim B., Strong M. A., Greider C. W. (2009). Short telomeres are sufficient to cause the degenerative defects associated with aging. PubMed DOI PMC

Armanios M., Blackburn E. H. (2012). The telomere syndromes. PubMed DOI PMC

Armstrong L., Saretzki G., Peters H., Wappler I., Evans J., Hole N., et al. (2005). Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. PubMed DOI

Baerlocher G. M., Rovo A., Muller A., Matthey S., Stern M., Halter J., et al. (2009). Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex. PubMed DOI

Balakumaran A., Mishra P. J., Pawelczyk E., Yoshizawa S., Sworder B. J., Cherman N., et al. (2015). Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders. PubMed DOI PMC

Ballew B. J., Savage S. A. (2013). Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. PubMed DOI

Barbaro P., Vedi A. (2016). Survival after hematopoietic stem cell transplant in patients with dyskeratosis congenita: systematic review of the literature. PubMed DOI

Batista L. F., Pech M. F., Zhong F. L., Nguyen H. N., Xie K. T., Zaug A. J., et al. (2011). Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. PubMed DOI PMC

Bhattacharjee R. N., Banerjee B., Akira S., Hande M. P. (2010). Telomere-mediated chromosomal instability triggers TLR4 induced inflammation and death in mice. PubMed DOI PMC

Blackburn E. H. (1991). Structure and function of telomeres. PubMed DOI

Blackburn E. H. (2001). Switching and signaling at the telomere. PubMed DOI

Blasco M. A., Lee H. W., Hande M. P., Samper E., Lansdorp P. M., DePinho R. A., et al. (1997). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. PubMed DOI

Buendia P., Carracedo J., Soriano S., Madueno J. A., Ortiz A., Martin-Malo A., et al. (2015). Klotho prevents NFkappaB translocation and protects endothelial cell from senescence induced by uremia. PubMed DOI

Calado R. T., Dumitriu B. (2013). Telomere dynamics in mice and humans. PubMed DOI PMC

Cawthon R. M. (2002). Telomere measurement by quantitative PCR. PubMed DOI PMC

Cawthon R. M., Smith K. R., O’Brien E., Sivatchenko A., Kerber R. A. (2003). Association between telomere length in blood and mortality in people aged 60 years or older. PubMed DOI

Chen J., Bryant M. A., Dent J. J., Sun Y., Desierto M. J., Young N. S. (2015). Hematopoietic lineage skewing and intestinal epithelia degeneration in aged mice with telomerase RNA component deletion. PubMed DOI PMC

Chiu C. P., Dragowska W., Kim N. W., Vaziri H., Yui J., Thomas T. E., et al. (1996). Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. PubMed DOI

Damm K., Hemmann U., Garin-Chesa P., Hauel N., Kauffmann I., Priepke H., et al. (2001). A highly selective telomerase inhibitor limiting human cancer cell proliferation. PubMed DOI PMC

Deelen J., Beekman M., Codd V., Trompet S., Broer L., Hagg S., et al. (2014). Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers. PubMed DOI PMC

Delhommeau F., Thierry A., Feneux D., Lauret E., Leclercq E., Courtier M. H., et al. (2002). Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant. PubMed DOI

Effros R. B. (2011). Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress. PubMed DOI PMC

Ergen A. V., Boles N. C., Goodell M. A. (2012). Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing. PubMed DOI PMC

Fernandez Garcia M. S., Teruya-Feldstein J. (2014). The diagnosis and treatment of dyskeratosis congenita: a review. PubMed PMC

Flores I., Cayuela M. L., Blasco M. A. (2005). Effects of telomerase and telomere length on epidermal stem cell behavior. PubMed DOI

Fok W. C., Niero E. L. O., Dege C., Brenner K. A., Sturgeon C. M., Batista L. F. Z. (2017). p53 mediates failure of human definitive hematopoiesis in dyskeratosis congenita. PubMed DOI PMC

Gazzaniga F. S., Blackburn E. H. (2014). An antiapoptotic role for telomerase RNA in human immune cells independent of telomere integrity or telomerase enzymatic activity. PubMed DOI PMC

Gizard F., Heywood E. B., Findeisen H. M., Zhao Y., Jones K. L., Cudejko C., et al. (2011). Telomerase activation in atherosclerosis and induction of telomerase reverse transcriptase expression by inflammatory stimuli in macrophages. PubMed DOI PMC

Goldman F. D., Aubert G., Klingelhutz A. J., Hills M., Cooper S. R., Hamilton W. S., et al. (2008). Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita. PubMed DOI PMC

Greider C. W., Blackburn E. H. (1985). Identification of a specific telomere terminal transferase activity in PubMed DOI

Hiyama E., Hiyama K. (2007). Telomere and telomerase in stem cells. PubMed DOI PMC

Hoffmeyer K., Raggioli A., Rudloff S., Anton R., Hierholzer A., Del Valle I., et al. (2012). Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells. PubMed DOI

Holohan B., Wright W. E., Shay J. W. (2014). Cell biology of disease: telomeropathies: an emerging spectrum disorder. PubMed DOI PMC

Hrdlickova R., Nehyba J., Bose H. R., Jr. (2009). Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells. PubMed DOI PMC

Hsieh M. H., Chen Y. T., Chen Y. T., Lee Y. H., Lu J., Chien C. L., et al. (2017). PARP1 controls KLF4-mediated telomerase expression in stem cells and cancer cells. PubMed DOI PMC

Huang J., Wang F., Okuka M., Liu N., Ji G., Ye X., et al. (2011). Association of telomere length with authentic pluripotency of ES/iPS cells. PubMed DOI PMC

Huang Y., Liang P., Liu D., Huang J., Songyang Z. (2014). Telomere regulation in pluripotent stem cells. PubMed DOI PMC

Imamura S., Uchiyama J., Koshimizu E., Hanai J., Raftopoulou C., Murphey R. D., et al. (2008). A non-canonical function of zebrafish telomerase reverse transcriptase is required for developmental hematopoiesis. PubMed DOI PMC

Jose S. S., Bendickova K., Fric J. (2018). High-throughput screening of senescence markers in hematopoietic stem cells derived from induced pluripotent stem cells. PubMed DOI

Jose S. S., Bendickova K., Kepak T., Krenova Z., Fric J. (2017). Chronic inflammation in immune aging: role of pattern recognition receptor crosstalk with the telomere complex? PubMed DOI PMC

Ju Z., Jiang H., Jaworski M., Rathinam C., Gompf A., Klein C., et al. (2007). Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment. PubMed DOI

Kim K., Doi A., Wen B., Ng K., Zhao R., Cahan P., et al. (2010). Epigenetic memory in induced pluripotent stem cells. PubMed DOI PMC

Knudson M., Kulkarni S., Ballas Z. K., Bessler M., Goldman F. (2005). Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. PubMed DOI

Kumar M., Witt B., Knippschild U., Koch S., Meena J. K., Heinlein C., et al. (2013). CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis. PubMed DOI

Lee J., Kook H., Chung I., Kim H., Park M., Kim C., et al. (1999). Telomere length changes in patients undergoing hematopoietic stem cell transplantation. PubMed DOI

Lehmann G., Muradian K. K., Fraifeld V. E. (2013). Telomere length and body temperature-independent determinants of mammalian longevity? PubMed DOI PMC

Li S., Ferguson M. J., Hawkins C. J., Smith C., Elwood N. J. (2006). Human telomerase reverse transcriptase protects hematopoietic progenitor TF-1 cells from death and quiescence induced by cytokine withdrawal. PubMed DOI

Liang Y., Van Zant G., Szilvassy S. J. (2005). Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. PubMed DOI PMC

Lin Y., Damjanovic A., Metter E. J., Nguyen H., Truong T., Najarro K., et al. (2015). Age-associated telomere attrition of lymphocytes in vivo is co-ordinated with changes in telomerase activity, composition of lymphocyte subsets and health conditions. PubMed DOI PMC

Lingner J., Hughes T. R., Shevchenko A., Mann M., Lundblad V., Cech T. R. (1997). Reverse transcriptase motifs in the catalytic subunit of telomerase. PubMed DOI

Lopez-Otin C., Blasco M. A., Partridge L., Serrano M., Kroemer G. (2013). The hallmarks of aging. PubMed DOI PMC

Marsh J. C., Will A. J., Hows J. M., Sartori P., Darbyshire P. J., Williamson P. J., et al. (1992). ”Stem cell” origin of the hematopoietic defect in dyskeratosis congenita. PubMed

Melguizo-Sanchis D., Xu Y., Taheem D., Yu M., Tilgner K., Barta T., et al. (2018). iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors. PubMed DOI PMC

Merino A., Buendia P., Martin-Malo A., Aljama P., Ramirez R., Carracedo J. (2011). Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. PubMed DOI

Mitchell J. R., Wood E., Collins K. (1999). A telomerase component is defective in the human disease dyskeratosis congenita. PubMed DOI

Morrison S. J., Prowse K. R., Ho P., Weissman I. L. (1996a). Telomerase activity in hematopoietic cells is associated with self-renewal potential. PubMed DOI

Morrison S. J., Wandycz A. M., Akashi K., Globerson A., Weissman I. L. (1996b). The aging of hematopoietic stem cells. PubMed DOI

Nelson N. D., Bertuch A. A. (2012). Dyskeratosis congenita as a disorder of telomere maintenance. PubMed DOI PMC

Ng E. S., Davis R. P., Hatzistavrou T., Stanley E. G., Elefanty A. G. (2008a). Directed differentiation of human embryonic stem cells as spin embryoid bodies and a description of the hematopoietic blast colony forming assay. PubMed DOI

Ng E. S., Davis R., Stanley E. G., Elefanty A. G. (2008b). A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. PubMed DOI

Ouellette M. M., Aisner D. L., Savre-Train I., Wright W. E., Shay J. W. (1999). Telomerase activity does not always imply telomere maintenance. PubMed DOI

Palm W., de Lange T. (2008). How shelterin protects mammalian telomeres. PubMed DOI

Park J. I., Venteicher A. S., Hong J. Y., Choi J., Jun S., Shkreli M., et al. (2009). Telomerase modulates Wnt signalling by association with target gene chromatin. PubMed DOI PMC

Perdigones N., Perin J. C., Schiano I., Nicholas P., Biegel J. A., Mason P. J., et al. (2016). Clonal hematopoiesis in patients with dyskeratosis congenita. PubMed DOI PMC

Pereboeva L., Westin E., Patel T., Flaniken I., Lamb L., Klingelhutz A., et al. (2013). DNA damage responses and oxidative stress in dyskeratosis congenita. PubMed DOI PMC

Plunkett F. J., Franzese O., Finney H. M., Fletcher J. M., Belaramani L. L., Salmon M., et al. (2007). The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation. PubMed DOI

Raval A., Behbehani G. K., Nguyen le X. T., Thomas D., Kusler B., Garbuzov A., et al. (2015). Reversibility of defective hematopoiesis caused by telomere shortening in telomerase knockout mice. PubMed DOI PMC

Riou J. F., Guittat L., Mailliet P., Laoui A., Renou E., Petitgenet O., et al. (2002). Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. PubMed DOI PMC

Rosenbauer F., Tenen D. G. (2007). Transcription factors in myeloid development: balancing differentiation with transformation. PubMed DOI

Samper E., Flores J. M., Blasco M. A. (2001). Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/- mice with short telomeres. PubMed DOI PMC

Shao L., Wang Y., Chang J., Luo Y., Meng A., Zhou D. (2013). Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury. PubMed PMC

Sharpless N. E., DePinho R. A. (2007). How stem cells age and why this makes us grow old. PubMed DOI

Stanley S. E., Armanios M. (2015). The short and long telomere syndromes: paired paradigms for molecular medicine. PubMed DOI PMC

Strong M. A., Vidal-Cardenas S. L., Karim B., Yu H., Guo N., Greider C. W. (2011). Phenotypes in mTERT(+)/(-) and mTERT(-)/(-) mice are due to short telomeres, not telomere-independent functions of telomerase reverse transcriptase. PubMed DOI PMC

Taniguchi Ishikawa E., Gonzalez-Nieto D., Ghiaur G., Dunn S. K., Ficker A. M., Murali B., et al. (2012). Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells. PubMed DOI PMC

Tian X., Doerig K., Park R., Can Ran, Qin A., Hwang C.et al. (2018). Evolution of telomere maintenance and tumour suppressor mechanisms across mammals. PubMed DOI PMC

Tian X., Kaufman D. S. (2008). Hematopoietic development of human embryonic stem cells in culture. PubMed DOI

Townsley D. M., Dumitriu B., Young N. S. (2014). Bone marrow failure and the telomeropathies. PubMed DOI PMC

Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. (1980). Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). PubMed DOI

von Zglinicki T., Martin-Ruiz C. M. (2005). Telomeres as biomarkers for ageing and age-related diseases. PubMed DOI

Vulliamy T., Marrone A., Goldman F., Dearlove A., Bessler M., Mason P. J., et al. (2001). The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. PubMed DOI

Wang J., Lu X., Sakk V., Klein C. A., Rudolph K. L. (2014a). Senescence and apoptosis block hematopoietic activation of quiescent hematopoietic stem cells with short telomeres. PubMed DOI PMC

Wang L., Xiao H., Zhang X., Wang C., Huang H. (2014b). The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation. PubMed DOI PMC

Winkler T., Hong S. G., Decker J. E., Morgan M. J., Wu C., Hughes W., et al. (2013). Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs. PubMed DOI PMC

Wong C. W., Hou P. S., Tseng S. F., Chien C. L., Wu K. J., Chen H. F., et al. (2010). Kruppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells. PubMed DOI

Wong J. M., Collins K. (2006). Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. PubMed DOI PMC

Wynn R., Thornley I., Freedman M., Saunders E. F. (1999). Telomere shortening in leucocyte subsets of long-term survivors of allogeneic bone marrow transplantation. PubMed DOI

Wynn R. F., Cross M. A., Hatton C., Will A. M., Lashford L. S., Dexter T. M., et al. (1998). Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. PubMed DOI

Yehuda S., Yanai H., Priel E., Fraifeld V. E. (2017). Differential decrease in soluble and DNA-bound telomerase in senescent human fibroblasts. PubMed DOI

Yu J., Hu K., Smuga-Otto K., Tian S., Stewart R., Slukvin I. I., et al. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. PubMed DOI PMC

Immunosenescence in Childhood Cancer Survivors and in Elderly: A Comparison and Implication for Risk Stratification